How is acquired angioedema (AAE) due to C1 inhibitor (C1-INH) deficiency (C1-INH-AAE) diagnosed?

Updated: May 20, 2020
  • Author: Amanda T Moon, MD; Chief Editor: William D James, MD  more...
  • Print
Answer

Screening is conducted by determining the C4 level, which is decreased both during and in between clinical flares. If the C4 level is normal but clinical suspicion remains high, the C4 testing should be repeated, and, additionally, qualitative and functional values of C1 inhibitor (C1-INH) should be obtained. Antigenic levels of C1q are usually low and are useful to distinguish hereditary angioedema from acquired angioedema. [2]

Test results for acquired angioedema types I and II are as follows:

  • Low C1-INH level

  • Low C1q levels (except 1 reported case)

  • Low C4 and C2 levels

Acquired angioedema type II shows positive immunoblot assay findings for the 95-kd C1-INH cleavage product.

An enzyme-linked immunosorbent assay (ELISA) has been developed that measures the neutralizing capacity of anti-C1-INH antibodies in plasma. [12]

Other laboratory findings are related to associated illnesses.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!